Latest news
13-04-2023 - 2023 Edition of ALS Association Clinical Trial Awards (CTA) Programme Launched
Applications are now open for the 2023 ALS Clinical Trial Awards (CTA).The funding, open to researchers worldwide, will support clinical trials into amyotrophic lateral sclerosis (ALS)/motor neurone disease (MND) treatment.
The ALS Association is an American non-profit organisation founded in 1985. Its mission is to lead the fight to treat and cure amyotrophic lateral sclerosis (ALS)/motor neurone disease (MND) through global research and nationwide advocacy, while also empowering ALS patients and their families to live fuller lives by providing them with compassionate care and support.
[...]